Pharm exam #3

Question

Which of the following is not safe during pregnancy?

Answer 1

None are safe during pregnancy

Answer 2

Decrease in Ca

Answer 3

Decrease in K

Answer 4

Increase in Mg

Answer 5

Increase in Glucose

Answer 6

Hyponatremia

Answer 7

Metabolic alkalosis

Answer 8

Hypouricemia

Answer 9

Sexual dysfunction

Answer 10

Eptifibatide

Answer 11

Electrolyte imbalance

Answer 12

Local pain and venous irritation

Answer 13

Acute renal failure

Answer 14

Low bioavailability

Answer 15

Monitored with PTT

Answer 16

Inexpensive

Answer 17

Renally excreted

Answer 18

Decrease in uric acid

Answer 19

Abdominal pain

Answer 20

Angioedema

Answer 21

It is more expensive than spironolactone

Answer 22

Less endocrine-related side effects than spironolactone

Answer 23

Lower chance of hyperkalemia

Answer 24

Higher affinity for aldosterone receptors

Answer 25

Hypotension

Answer 26

Gynecomastia

Answer 27

Hyperkalemia

Answer 28

Eplerenone

Answer 29

Aldosterone antagonists

Answer 30

Loop diuretics

Answer 31

Loop diuretics

Answer 32

Sodium channel blockers

Answer 33

Aldosterone receptor antagonists

Answer 34

By stimulating cGMP resulting in vascular smooth muscle relaxation

Answer 35

By being excreted unchanged and causing water to be retained within the proximal tubule and descending loop of Henle due to the freely permeable water

Answer 36

By blocking the epithelial sodium channels on principal cells and cause sodium excretion

Answer 37

By antagonizing vasopressing

Answer 38

Increase Mg

Answer 39

Increase Ca

Answer 40

Decrease glucose

Answer 41

Increase in potassium

Answer 42

Urinary frequency

Answer 43

Visual disturbances

Answer 44

Liver cirrhosis

Answer 45

Fondaparinux

Answer 46

Argatraban

Answer 47

Metolazone and Bumetanide

Answer 48

HCTZ and ARB

Answer 49

ACEI and ARBs

Answer 50

Furosemide and Lisinopril

Answer 51

Fondaparinux

Answer 52

Eptifibatide

Answer 53

Because you want to deactivate antithrombin

Answer 54

It takes about 5 days to replace activated clotting factors with dysfunctional clotting factors

Answer 55

It takes about 5 days to replace Protein C and Protein S

Answer 56

You should never overlap warfarin with LMWH or UFH

Answer 57

Ticagrelor

Answer 58

Clopidogrel

Answer 59

Ticlopidine

Answer 60

Epoprosternol

Answer 61

Treprostinil (Remodulin)

Answer 62

Treprostinil (Tyvaso)

Answer 63

Dabigatran

Answer 64

Direct X inhibitors

Answer 65

Indirect X inhibitors

Answer 66

Ticlopidine

Answer 67

Ticagrelor

Answer 68

Ticagrelor

Answer 69

Ticlopidine

Answer 70

Clopidogrel

Answer 71

Ticagrelor

Answer 72

Clopidogrel

Answer 73

Ticlopidine

Answer 74

Ticagrelor

Answer 75

Clopidogrel

Answer 76

Ticlopidine

Answer 77

To decrease the platelet count.

Answer 78

To prevent a prothrombotic condition

Answer 79

To prevent bleeding.

Answer 80

To induce a prothrombotic condition

Answer 81

Stop heparin products

Answer 82

Stop warfarin until platelet count is above 150,000

Answer 83

Use alternative anticoagulants

Answer 84

Give a high dose of warfarin when restarting

Answer 85

Calcitriol

Answer 86

Monitored by PTT

Answer 87

Hepatic elimination

Answer 88

Decrease in INR

Answer 89

Can be used for treatment of HIT

Answer 90

Heparin/LMWH

Answer 91

Fondaparinux

Answer 92

It causes less GI bleeding than dabigatran

Answer 93

It causes more GI bleed than Rivaroxaban

Answer 94

It causes less GI bleeds than Apixaban

Answer 95

It causes less ICH in Direct Factor X inhibitors and Dabigatran

Answer 96

Rivaroxaban

Answer 97

Metabolic acidosis

Answer 98

Kidney stones

Answer 99

Paresthesia

Answer 100

Hypernatremia

Answer 101

Renal dysfunction

Answer 102

Increasing dose during therapy

Answer 103

Increasing duration of therapy

Answer 104

Safe to use in COPD patients

Answer 105

Has a slightly better metabolic effect

Answer 106

Loses selectivity at lower doses

Answer 107

Has little effect in patients with reversible airway disease

Answer 108

To decrease production of aqueous humor

Answer 109

To decrease HR

Answer 110

To decrease contractility

Answer 111

To decrease portal hypertension

Answer 112

To inhibit vasodilatation or arteriolar spasms over the cortex

Answer 113

To decrease oxygen demand

Answer 114

It directly affects factor X

Answer 115

It is renally excreted

Answer 116

It has a long half-life, so not good for bridging with warfarin

Answer 117

There is still risk of HIT

Answer 118

Carvedilol

Answer 119

Propranolol

Answer 120

Metoprolol

Answer 121

Potassium-sparing diuretics

Answer 122

Loop diuretics

Answer 123

Sodium channel blockers

Answer 124

PCC are more efficient than FFP

Answer 125

PCC is usually given in a large volume

Answer 126

FFP and PCC are given with Vitamin K

Answer 127

FFP has larger risk of thrombosis

Answer 128

Sodium and water retention

Answer 129

Hypertrichosis

Answer 130

Precipitation of angina

Answer 131

Induced MI

Answer 132

Prostanoids

Answer 133

Hydralazine

Answer 134

PDE-5 drugs

Answer 135

Epoprostenol

Answer 136

Treprostinil (Remodulin)

Answer 137

Trerostinil (Tyvaso)

Answer 138

Epoprostenol

Answer 139

Treprostinil (Remodulin)

Answer 140

Treprostinil (Tyvaso)

Answer 141

PDE-5 drugs

Answer 142

Sodium nitroprusside

Answer 143

Prostenoids

Answer 144

GP IIb/IIIA inhibitors

Answer 145

P2Y12 inhibitors

Answer 146

It's ability to block ETB receptor

Answer 147

Because of its vasoconstricting effects

Answer 148

Because of its ability to release NO to cause vasodilation

Answer 149

It's ability to block ETA receptor

Answer 150

Dabigatran

Answer 151

Hypothyroidism

Answer 152

Bactrim with use of warfarin

Answer 153

Short gut syndrome

Answer 154

By blocking sodium influx, causing calcium overload through the sodium/calcium exchanger

Answer 155

Blocking calcium channels, blocking calcium influx, causing dilation in arterial smooth muscle leading to decrease in afterload

Answer 156

Blocking calcium channels, blocking calcium influx, causing dilation in venous smooth muscle leading to decrease in afterload

Answer 157

Blocking calcium channels, blocking calcium influx, causing dilation in venous smooth muscle leading to decrease in preload

Answer 158

They cause arterial dilation

Answer 159

They are denitrated to NO, increasing cGMP and causing increase in dilation

Answer 160

They are denitrated to NO, decreasing cGMP and causing increase in dilation

Answer 161

Releases NO from the drug itself, causing vasodilation

Answer 162

Hypertension

Answer 163

Benign process

Answer 164

Iron deficiency

Answer 165

Pure white cell aplasia

Answer 166

Epinephrine and Norepinephrine

Answer 167

Dobutamine and Epinephrine

Answer 168

Norepinephrine and Dopamine

Answer 169

Phenylephrine and Dobutamine

Answer 170

Dobutamine

Answer 171

Epinephrine

Answer 172

Phenylephrine

Answer 173

Floppy Iris Syndrome

Answer 174

Prolonged QT interval

Answer 175

Bradycardia

Answer 176

Orthostatic hypertension

Answer 177

GI symptoms

Answer 178

Ototoxicity

Answer 179

Metabolic acidosis

Answer 180

Hyperkalemia

Answer 181

Iron dextran

Answer 182

Ferric gluconate

Answer 183

Ferumoxytol

Answer 184

Ferric carboxymaltose

Answer 185

Iron dextran

Answer 186

Ferric gluconate

Answer 187

Ferumoxytol

Answer 188

Ferric carboxymaltose

Answer 189

Hypomagnesemia

Answer 190

Hypocalcemia

Answer 191

Hypernatremia

Answer 192

Ototoxicity

Answer 193

Calcium carbonate

Answer 194

Calcium acetate

Answer 195

Propafenone

Answer 196

Propranolol

Answer 197

Amiodarone

Answer 198

beta-blocker

Answer 199

potassium channel blocker

Answer 200

sodium channel blocker

Answer 201

calcium channel blocker

Answer 202

for atrial arrhythmias

Answer 203

the strongest among the sodium channel blockers

Answer 204

used as a local anesthetic

Answer 205

a class IC drug

Answer 206

Flecainide

Answer 207

Propafenone

Answer 208

Amiodarone

Answer 209

Dofetilide

Answer 210

Dofetilide

Answer 211

Procainamide

Answer 212

Pulmonary fibrosis

Answer 213

Increase in iodine

Answer 214

Photosensitivity

Answer 215

These are all side effects of Amiodarone

Answer 216

Propafenone

Answer 217

Flecainide

Answer 218

Procainamide

Answer 219

Dofetilide

Answer 220

Amiodarone

Answer 221

Causes vasodilation in healthy arteries, revealing the diseased coronary arteries

Answer 222

Causes vasoconstriction in healthy arteries, revealing the diseased coronary arteries

Answer 223

Causes vasodilation in diseased arteries, revealing the healthy coronary arteries

Answer 224

Causes vasoconstriction in diseased arteries, revealing healthy coronary arteries

Answer 225

Inhibits potassium channels, decreasing intracellular potassium

Answer 226

Inhibits sodium-potassium ATPase, increasing sodium concentration thereby increasing calcium concentration

Answer 227

Causes negative inotropic effects

Answer 228

Causes positive dromotropic/chronotropic effects

Answer 229

Shorter half life than dronedarone

Answer 230

Slightly more effective than dronedarone in Afib patients

Answer 231

High risk of side effects

Answer 232

More GI side effects

Answer 233

I2 in structure and effects thyroid

Answer 234

Does not have negative inotropic effects

Answer 235

Cannot be used for CHF

Answer 236

They dilate arterial smooth muscle

Answer 237

Mostly effects the sodium channels in atrial and ventricular tissues and Purkinjie fibers

Answer 238

Acts on the SA and AV node

Answer 239

Blocks sodium channels

Answer 240

Should be continued in patients who are already on a beta blocker

Answer 241

Use of them perioperatively in any situation is standard of practice

Answer 242

Perioperative beta blockage started within one day or less before noncardiac surgery decreases risk of stroke, death, hypotension, and bradycardia

Answer 243

It is not a clinical contreversy

Answer 244

Dronedarone

Answer 245

Beta-blockers

Answer 246

Felcainide

Answer 247

Beta blockers

Answer 248

Class IA drugs

Answer 249

Class IB drugs

Answer 250

Calcium channel blockers

Answer 251

Propafenone

Answer 252

Dofetilide

Answer 253

Dofetilide

Answer 254

Propafenone

	Erstellt von Diana Flores vor etwa 9 Jahre

Nächster

Pharm exam #3

Beschreibung

Zusammenfassung der Ressource

Frage 1

Frage 2

Frage 3

Frage 4

Frage 5

Frage 6

Frage 7

Frage 8

Frage 9

Frage 10

Frage 11

Frage 12

Frage 13

Frage 14

Frage 15

Frage 16

Frage 17

Frage 18

Frage 19

Frage 20

Frage 21

Frage 22

Frage 23

Frage 24

Frage 25

Frage 26

Frage 27

Frage 28

Frage 29

Frage 30

Frage 31

Frage 32

Frage 33

Frage 34

Frage 35

Frage 36

Frage 37

Frage 38

Frage 39

Frage 40

Frage 41

Frage 42

Frage 43

Frage 44

Frage 45

Frage 46

Frage 47

Frage 48

Frage 49

Frage 50

Frage 51

Frage 52

Frage 53

Frage 54

Frage 55

Frage 56

Frage 57

Frage 58

Frage 59

Frage 60

Frage 61

Frage 62

Frage 63

Frage 64

Frage 65

Frage 66

Frage 67

Frage 68

Frage 69

Frage 70

Frage 71

Frage 72

Frage 73

Frage 74

Frage 75

Frage 76